These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35209968)

  • 1. Effect of proton pump inhibitors on the development of hypomagnesemia induced by panitumumab.
    Morii Y; Fujimoto S; Nakahara R; Okawa K; Senaha H; Fujiwara K; Tsubaki M; Matzno S; Takegami M; Shimomura K; Nishida S
    Pharmazie; 2022 Feb; 77(2):81-84. PubMed ID: 35209968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Evaluation of Proton Pump Inhibitors for Panitumumab-Related Hypomagnesemia in Patients with Metastatic Colorectal Cancer.
    Katsura H; Suga Y; Kubo A; Sugimura H; Kumatani K; Haruki K; Yonezawa M; Narita A; Ishijima R; Ikesue H; Toi H; Takata N
    Biol Pharm Bull; 2024; 47(1):98-103. PubMed ID: 38171783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of oral magnesium-containing supplement and antacid administration on hypomagnesemia induced by panitumumab.
    Sato J; Ishikawa H; Tanaka R; Sino M
    Cancer Chemother Pharmacol; 2019 Apr; 83(4):673-679. PubMed ID: 30661095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying optimal magnesium replenishment points based on risk of severe hypomagnesemia in colorectal cancer patients treated with cetuximab or panitumumab.
    Kimura M; Usami E; Teramachi H; Yoshimura T
    Cancer Chemother Pharmacol; 2020 Sep; 86(3):383-391. PubMed ID: 32789758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton pump inhibitors not associated with hypomagnesemia, regardless of dose or concomitant diuretic use.
    Chowdhry M; Shah K; Kemper S; Zekan D; Carter W; McJunkin B
    J Gastroenterol Hepatol; 2018 Oct; 33(10):1717-1721. PubMed ID: 29514412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Association between the Use of Proton Pump Inhibitors and the Risk of Hypomagnesemia in a National Cohort of Veteran Patients with HIV.
    Sutton SS; Magagnoli J; Cummings T; Hardin JW
    J Int Assoc Provid AIDS Care; 2019; 18():2325958218821652. PubMed ID: 30798693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Retrospective Investigation of the Risk Factors for Severity in Panitumumab-Induced Hypomagnesemia].
    Nakazawa Y; Ando N; Harada D; Kitamura M; Aiba K; Kawakubo T
    Gan To Kagaku Ryoho; 2018 Oct; 45(10):1435-1440. PubMed ID: 30382040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in cetuximab-induced skin rash and hypomagnesemia in patients receiving concomitant treatment with proton pump inhibitors (PPIs): a possible drug interaction?
    Abu-Amna M; Bar-Sela G
    Cancer Chemother Pharmacol; 2019 Mar; 83(3):545-550. PubMed ID: 30547192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study.
    Kieboom BC; Kiefte-de Jong JC; Eijgelsheim M; Franco OH; Kuipers EJ; Hofman A; Zietse R; Stricker BH; Hoorn EJ
    Am J Kidney Dis; 2015 Nov; 66(5):775-82. PubMed ID: 26123862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and risk factors of long-term proton pump inhibitors-associated hypomagnesemia: a cross-sectional study in hospitalized patients.
    Recart DA; Ferraris A; Petriglieri CI; Alonso Serena M; Bonella MB; Posadas-Martinez ML
    Intern Emerg Med; 2021 Apr; 16(3):711-717. PubMed ID: 33001349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton Pump Inhibitors and Hypomagnesemia in Older Inpatients: An Observational Study.
    Anna Vermeulen Windsant-van den Tweel AM; Derijks HJ; Gadiot NPPM; Keijsers CJPW
    Sr Care Pharm; 2022 Dec; 37(12):623-630. PubMed ID: 36461136
    [No Abstract]   [Full Text] [Related]  

  • 12. The association of proton pump inhibitors and hypomagnesemia in the community setting.
    Markovits N; Loebstein R; Halkin H; Bialik M; Landes-Westerman J; Lomnicky J; Kurnik D
    J Clin Pharmacol; 2014 Aug; 54(8):889-95. PubMed ID: 24771616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low Prevalence of Hypomagnesemia in Long-term Recipients of Proton Pump Inhibitors in a Managed Care Cohort.
    Sharara AI; Chalhoub JM; Hammoud N; Harb AH; Sarkis FS; Hamadeh G
    Clin Gastroenterol Hepatol; 2016 Feb; 14(2):317-21. PubMed ID: 26499924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical predictors associated with proton pump inhibitor-induced hypomagnesemia.
    Kim S; Lee H; Park CH; Shim CN; Lee HJ; Park JC; Shin SK; Lee SK; Lee YC; Kim HY; Kang DR
    Am J Ther; 2015; 22(1):14-21. PubMed ID: 23846522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton Pump Inhibitor Use, Hypomagnesemia and Risk of Cardiovascular Diseases: The Atherosclerosis Risk in Communities (ARIC) Study.
    Rooney MR; Bell EJ; Alonso A; Pankow JS; Demmer RT; Rudser KD; Chen LY; Lutsey PL
    J Clin Gastroenterol; 2021 Sep; 55(8):677-683. PubMed ID: 33471493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypomagnesemia as a predictor of mortality in hemodialysis patients and the role of proton pump inhibitors: A cross-sectional, 1-year, retrospective cohort study.
    Ago R; Shindo T; Banshodani M; Shintaku S; Moriishi M; Masaki T; Kawanishi H
    Hemodial Int; 2016 Oct; 20(4):580-588. PubMed ID: 27329549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton pump inhibitor use for 12 months is not associated with changes in serum magnesium levels: a prospective open label comparative study.
    Bahtiri E; Islami H; Hoxha R; Gashi A; Thaçi K; Karakulak Ç; Thaçi S; Qorraj Bytyqi H
    Turk J Gastroenterol; 2017 Mar; 28(2):104-109. PubMed ID: 28082254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton pump inhibitors linked to hypomagnesemia: a systematic review and meta-analysis of observational studies.
    Cheungpasitporn W; Thongprayoon C; Kittanamongkolchai W; Srivali N; Edmonds PJ; Ungprasert P; O'Corragain OA; Korpaisarn S; Erickson SB
    Ren Fail; 2015 Aug; 37(7):1237-41. PubMed ID: 26108134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse event profiles of hypomagnesemia caused by proton pump inhibitors using the Japanese Adverse Drug Event Report (JADER) Database.
    Yamashiro K; Hosomi K; Yokoyama S; Ogata F; Nakamura T; Kawasaki N
    Pharmazie; 2022 Sep; 77(7):243-247. PubMed ID: 36199184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton-pump inhibitors do not influence serum magnesium levels in renal transplant recipients.
    Van Ende C; Van Laecke S; Marechal C; Verbeke F; Kanaan N; Goffin E; Vanholder R; Jadoul M
    J Nephrol; 2014 Dec; 27(6):707-11. PubMed ID: 24816563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.